We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
MDGL

Price
317.15
Stock movement up
+9.80 (3.19%)
Company name
Madrigal Pharmaceuticals Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
6.92B
Ent value
6.98B
Price/Sales
89.16
Price/Book
8.90
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
55.24%
1 year return
29.62%
3 year return
49.30%
5 year return
38.24%
10 year return
15.58%
Last updated: 2025-04-12

iO Charts is a Seeking Alpha partner

DIVIDENDS

MDGL does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales89.16
Price to Book8.90
EV to Sales89.98

FINANCIALS

Per share

Loading...
Per share data
Current share count21.81M
EPS (TTM)-23.85
FCF per share (TTM)-20.16

Income statement

Loading...
Income statement data
Revenue (TTM)77.58M
Gross profit (TTM)74.22M
Operating income (TTM)-548.05M
Net income (TTM)-518.67M
EPS (TTM)-23.85
EPS (1y forward)-13.37

Margins

Loading...
Margins data
Gross margin (TTM)95.66%
Operating margin (TTM)-706.41%
Profit margin (TTM)-668.54%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash232.68M
Net receivables30.46M
Total current assets1.06B
Goodwill0.00
Intangible assets4.82M
Property, plant and equipment4.78M
Total assets1.07B
Accounts payable45.97M
Short/Current long term debt119.14M
Total current liabilities177.85M
Total liabilities296.11M
Shareholder's equity777.15M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-431.02M
Capital expenditures (TTM)7.30M
Free cash flow (TTM)-438.32M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-66.74%
Return on Assets-48.33%
Return on Invested Capital-57.94%
Cash Return on Invested Capital-48.97%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open309.38
Daily high324.14
Daily low304.06
Daily Volume391K
All-time high409.85
1y analyst estimate373.00
Beta-0.47
EPS (TTM)-23.85
Dividend per share-
Ex-div date-
Next earnings date5 May 2025

Downside potential

Loading...
Downside potential data
MDGLS&P500
Current price drop from All-time high-22.62%-12.89%
Highest price drop-98.40%-56.47%
Date of highest drop11 Feb 20169 Mar 2009
Avg drop from high-61.25%-11.07%
Avg time to new high458 days12 days
Max time to new high3072 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
MDGL (Madrigal Pharmaceuticals Inc) company logo
Marketcap
6.92B
Marketcap category
Mid-cap
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.
Employees
376
Investor relations
-
SEC filings
CEO
Paul A. Friedman
Country
USA
City
West Conshohocken
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...